Sofosbuvirvelpatasvirvoxilaprevir for treating chronic hepatitis C

These new evidence-based recommendations on sofosbuvir –velpatasvir–voxilaprevir (Vosevi) for treating chronic hepatitis C in adults were published in February 2018.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news